Publication | Closed Access

Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease

Combinatorial ChemistryMedicinal ChemistryDerivative (Chemistry)Natural SciencesMedicineOrganic ChemistryN-aryl Piperazine MoietyChemistryPharmacologyPharmaceutical ChemistryMulti-targetable Chalcone DerivativesDrug Discovery